The Canadian Cancer Research Alliance (CCRA) is an alliance of organizations that collectively fund most of the cancer research conducted in Canada – research that will lead to:
Members include federal research funding programs/agencies, provincial research agencies, provincial cancer care agencies, cancer charities, and other voluntary associations.
We are motivated by the belief that, through effective collaboration, Canadian cancer research funding organizations can maximize their collective impact on cancer control and accelerate discovery for the ultimate benefit of Canadians affected by cancer.
Our Executive Office is supported by the Canadian Partnership Against Cancer, an independent, not-for-profit organization funded by the federal government to accelerate action on cancer control for all Canadians. For more information on the Partnership’s role, click here.
The CCRA is not a registered charity and cannot accept donations. If you wish to donate to a charity that funds cancer research, please check our Members page.
We need you to help define the future of cancer research in Canada!
On behalf of the cancer research community, the Canadian Cancer Research Alliance (CCRA) in collaboration with Shift Health, is creating an exciting 20-year vision for cancer research in Canada. Our online survey is one way that you can contribute your ideas and opinions and we are hoping that researchers, persons affected by cancer, and members of the public will participate. It is your chance to dream big and think boldly about the potential for the cancer research system to ensure it remains leading-edge and addresses the pressing challenges associated with cancer. The survey should take no more than 15-20 minutes of your time. Click on this link to access the survey.
If you have any questions, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..
As companions to our 2016 special topic reports, CCRA has released interactive 'story visualizations' using Tableau software. Story visualizations are dashboards that are linked sequentially. They walk users through a series of analyses, each with greater detail, and allowing users more opportunity to ‘interact’ with the data. We welcome your feedback!
To access these tools, click here.
The Partnership is pleased to announce a brand new section - Topics - on its website PartnershipAgainstCancer.ca. Topics is now home to the most valuable information from Cancerview.ca, which has just been sunsetted. Topics provides evidence-based information for the cancer control community and is user-friendly, optimized for search engines, viewable on all devices, and accessible. Go to Topics and let the Partnership know what you think!
CCRA released its latest reports on the investment in cancer research. In addition to the overview report, there are brief reports on the research investments made in childhood and adolescent cancers, cancer risk and prevention, cancer survivorship, palliative and end-of-life cancer care and translational research. Reports are available in PDF formats and have accompanying slide decks that expand on the report analyses.
To access the annual report, click here. For the special topics reports, click here.
In 2011, the CCRA initiated a biennial recognition program consisting of three awards to acknowledge and celebrate the contributions of individuals who have had a remarkable impact on cancer research and the cancer research community. In 2017, the CCRA announced a new award recognizing exceptional leadership in patient involvement in cancer research. These awards are presented during the Canadian Cancer Research Conference.
To submit a nomination, please provide the nominee’s name and a brief paragraph detailing the reasons for nomination to Diana Soifer (This email address is being protected from spambots. You need JavaScript enabled to view it.) by the end of day on May 15, 2019. Nominations are open to all, including past nominees.
This webinar will provide an overview of the Canadian Partnership for Tomorrow Project (CPTP) — Canada’s largest population study of more than 320,000 Canadians in six regional cohorts across the country — that allows researchers to explore how genetics, environment, lifestyle and behaviour interact and contribute to the development of cancer and other chronic diseases. Researchers are already integrating CPTP data into their own studies, generating valuable insights that may enable earlier detection, monitoring, and inform future interventions. Two case studies will explore how CPTP participant data is linked with cancer data to better understand disease risk, and another that linked participant and environment data to study gene-by-environment interactions.
Click here to register and learn more about CPTP’s capability to leverage massive datasets for population health research and how to access this data through the CPTP Portal. Webinar registration: https://zoom.us/webinar/register/WN_AyQ3fV2BRBGh_1JF3SGglQ
Prostate Cancer Canada invites members of the prostate cancer research community to submit an application to the Movember TAG. This request for applications is a multi-step process: expression of interest letters are due to June 27, 2019 and selected individuals will be brought together with the intention of collaborating and submitting an application that will have the greatest potential to demonstrate the value of incorporating advanced imaging modalities into prostate cancer management by designing and carrying out a prospective clinical trial that evaluates patient outcomes following image-guided treatment planning. The award amount is up to $ 3M over 3 years.
For complete details, go to http://www.prostatecancer.ca/Research/Current-Opportunities/Targeted-RFA-2019.
The Brain Tumour Foundation of Canada launched the first-ever Brain Tumour Registry of Canada (BTRC) – a surveillance research collaborative. Working as a nationwide, multicentre initiative, the BTRC will become a cornerstone to optimizing clinical outcomes using evidence-based decision making for the treatment and care of brain tumour patients across Canada. On May 14th, the first incidence report was released, covering four provinces and capturing 70% of the Canadian population. A further survival report will be released later this year and a comprehensive national report is anticipated in 2020. For more information and to access the report, go to www.braintumourregistry.ca.
Prostate Cancer Canada wants YOU to share what you know about prostate cancer to help them develop valuable health resources. After completing the 3 minute survey, you can enter to win a $100 gift card.
Please complete the survey and enter to win $100 here bit.ly/PCCquestionnaire
To learn more about Prostate Cancer Canada, please visit here: http://www.prostatecancer.ca.
The Terry Fox New Investigator Award provides research operating grants to support future leaders as they develop their independent careers in cancer research. The award provides a single research grant of up to $450,000 for three years to investigators within the first seven years of a first faculty-level appointment in Canada. New Investigators must be sponsored and mentored by an existing Terry Fox or Canadian Institutes of Health Research (CIHR) funded program. Registration of Intent: Friday, June 28, 2019 (5:00 pm PDT). For more information, click here.